Toggle Main Menu Toggle Search

Open Access padlockePrints

‘I Do It All Alone’: The Burdens and Benefits of Being Diagnosed With, and Treated for, Colorectal Cancer During the Covid-19 Pandemic

Lookup NU author(s): Dr Christina DobsonORCiD, Jennifer DeaneORCiD, Beth Osborne, Professor Colin Rees, Professor Linda Sharp

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 The Author(s). Health Expectations published by John Wiley & Sons Ltd.Introduction: The Covid-19 pandemic dramatically altered the way cancer care services were accessed and delivered, including for colorectal cancer (CRC). In the United Kingdom, patients were discouraged from presenting in primary care, many consultations took place remotely, investigative procedures and screening programmes were temporarily suspended, and fewer operations and treatments were delivered. People had to face the practical consequences of having cancer during a pandemic and navigate never before seen pathways, often alone. We examined the experience of being diagnosed and treated for CRC during the pandemic, and the implications of this on people's cancer journeys. Methods: Semi-structured interviews were undertaken with people diagnosed with CRC during the Covid-19 pandemic (January 2020–May 2021), in the North East of England. An iterative topic guide was used during interviews, which took place remotely (telephone or Zoom), were audio recorded, pseudo-anonymised and transcribed. Initial transcripts were independently coded by two researchers, and a code ‘bank’ developed for application across transcripts. Development of themes and overarching analytical constructs was undertaken collaboratively by the research team. Results: Interviews were conducted with 19 participants, analysed and four key themes identified: (1) The relative threats of Covid-19 and Cancer were not comparable, with cancer seen as posing a far greater risk than Covid-19; (2) Remote consultations were problematic, affecting patients' abilities to build rapport and trust with clinicians, assess nonverbal communication, and feel able to disclose, comprehend and retain information; (3) Stoma follow-up care was seen to be lacking, with long wait times for stoma reversal experienced by some; Finally, (4) Being alone during consultations negatively impacted some peoples' abilities to absorb information, and left them without the support of loved ones at an emotionally vulnerable time. However, some participants preferred being alone at certain points in their pathways, including receiving a diagnosis, and most frequently when receiving in-patient treatment. Conclusion: Being alone brought unexpected benefits, absolving people from undertaking emotions work for others, and instead focus on their recovery, however, remote consultations negatively impacted patients' experiences. This study highlights the complex benefits and burdens of pandemic-located cancer journeys, including how these shifted at different points across cancer pathways. Patient or Public Contribution: Lorraine Angell, a cancer survivor, has been central to this study from idea conception, contributing to: development of study focus and design; securing funding; production of patient-facing materials; development of interview topic guides; analysis and interpretation of data; and drafting of key findings and manuscripts.


Publication metadata

Author(s): Dobson CM, Deane J, Osborne B, Araujo-Soares V, Rees CJ, Angell L, Sharp L

Publication type: Article

Publication status: Published

Journal: Health Expectations

Year: 2024

Volume: 27

Issue: 3

Online publication date: 14/06/2024

Acceptance date: 24/05/2024

Date deposited: 24/06/2024

ISSN (print): 1369-6513

ISSN (electronic): 1369-7625

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1111/hex.14110

DOI: 10.1111/hex.14110

Data Access Statement: Redacted, anonymised data are available on request from the corresponding author. The data are not publicly available due to ethical restrictions.

PubMed id: 38872460


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
British Academy, Grant/Award Number: COV19\200122

Share